Sarcoma / 2017 / Article / Tab 1

Research Article

High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

Table 1

Patients characteristics at chemotherapy when starting ifosfamide.

Patients characteristics

Age, years
Median33
Range31–75

Histopathological diagnosis
Round cell myxoid liposarcoma (high grade)7 (63%)
Classical myxoid liposarcoma (low grade)4 (37%)

Metastatic disease at diagnosis2 (18%)
Localized disease at diagnosis9 (82%)

Adjuvant chemotherapy
Y8 (73%)
N3 (27%)

Adjuvant radiotherapy
Y7 (64%)
N4 (36%)

Number of sites involved
Median2
Range1–3

Local relapse4 (36%)

Metastatic sites
Lung8 (73%)
Abdominal cavity7 (64%)
Bone1 (9%)
Soft Tissue1 (9%)

Number of prior chemotherapy regimens
0 1 (10%)
1 5 (45%)
23 (27%)
3 2 (18%)

Prior chemotherapy
Anthracycline ± Ifosfamide11 (100%)
Trabectedin3 (27%)
Pemetrexed1 (10%)
Liposomal doxorubicin1 (9%)
Unknown2 (18%)

High-dose ifosfamide infusion
Elastomeric pump11 (100%)

Number of ifosfamide courses
Median3
Range(2–7)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.